Navigating the SEC’s Action Against Zymergen: Key Takeaways on Market Size Disclosures
On September 13, 2024, the SEC settled charges against Zymergen Inc. for misleading investors in its IPO by overstating market
On September 13, 2024, the SEC settled charges against Zymergen Inc. for misleading investors in its IPO by overstating market
Understanding Reg CF Resale Restrictions General rule: if you read the SEC rules with blinders on, you are probably well
One of the exciting things about securities law is that rules can and do change in response to concerns raised